Alglucerase Systematic (IUPAC) name Human beta-glucocerebrosidase Clinical data AHFS/Drugs.com MedlinePlus Pregnancy cat. ? Legal status ? Pharmacokinetic data Half-life 3.6–10.4 min Identifiers CAS number ATC code A16 DrugBank UNII KEGG ChEMBL Chemical data Formula C2532H3854N672O711S16 Mol. mass 55597.4 g/mol (what is this?)
Alglucerase is a modified form of human β-glucocerebrosidase where the non-reducing ends of the oligosaccharide chains have been terminated with mannose residues. Ceredase is the trade name of a citrate buffered solution of alglucerase manufactured by Genzyme Corporation from human placental tissue. It is given intravenously in the treatment of Type 1 Gaucher's disease although it has been largely replaced by imiglucerase which is produced by recombinant DNA technology.
Other alimentary tract and metabolism products (A16) Amino acids and derivatives EnzymesGlycosaminoglycan: iduronidase (Laronidase) • arylsulfatase B (Galsulfase) • iduronate-2-sulfatase (Idursulfase) Various alimentary tract
and metabolism products
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.